ÂÜÀòÂÒÂ×

Dr Werner Cautreels was President and CEO of Selecta Biosciences (Boston and Moscow) from July 2010 until his retirement in December 2018. He is now pursuing a portfolio career.

Previously, Dr Cautreels served as Global CEO of Solvay Pharmaceuticals until it was acquired by Abbott Laboratories in 2010. Prior to joining Solvay, he worked at Sanofi, Sterling Winthrop and Nycomed-Amersham in a variety of R&D management positions in Europe and the United States.

Dr Cautreels was also a Director of Innogenetics NV (Gent, Belgium) and of Arqule Inc. (Woburn, MA, USA). Until April 2019, Dr Cautreels was Director and Chair of the Audit Committee of Galapagos NV (Mechelen, Belgium). He was also the President of the Belgian Chamber of Commerce for Russia.

Dr Cautreels is currently Chairman of Cristal Therapeutics (Maastricht, The Netherlands) and of MRM Health (Gent, Belgium). Dr Cautreels has a PhD in chemistry from the University of Antwerp, Belgium and an Executive MBA from Harvard Business School, Massachusetts, USA.